Skip to main content

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of AMRX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders155157+2
Shares99.6M102.0M+2.39M (+2.4%)
Value$201.0M$202.7M+$1.70M (+0.8%)

New holders (30)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to AMRX in Q4 2022
InstitutionSharesValue% of portfolio
Norges Bank2,714,400$5.40M0.00%
Two Sigma Investments, LP578,180$1.15M0.00%
Graham Capital Management, L.P.534,829$1.06M0.04%
Arrowstreet Capital, Limited Partnership497,474$990.0K0.00%
XTX Topco Ltd191,502$381.1K0.08%
Gsa Capital Partners LLP175,049$348.0K0.04%
Alberta Investment Management Corp131,267$261.2K0.00%
State of Tennessee, Treasury Department104,193$207.0K0.00%
Assenagon Asset Management S.A.72,578$144.0K0.00%
HRT Financial LP65,354$130.0K0.00%
Alpine Global Management, LLC58,186$116.0K0.04%
Pension & Wealth Management Advisors, Inc.35,758$71.2K0.06%
Qube Research & Technologies Ltd31,556$62.8K0.00%
Mackenzie Financial Corp28,106$55.9K0.00%
Squarepoint Ops LLC23,057$45.9K0.00%
Dynamic Technology Lab Private Ltd21,976$44.0K0.00%
Tri Locum Partners LP21,622$43.0K0.02%
Engineers Gate Manager LP17,112$34.1K0.00%
Bank of Montreal13,296$31.0K0.00%
American Century Companies Inc15,166$30.2K0.00%
Prelude Capital Management, LLC12,562$25.0K0.00%
Point72 Middle East FZE11,832$23.5K0.00%
Verition Fund Management LLC11,600$23.1K0.00%
Park Place Capital Corp1,916$4.00K0.00%
Belpointe Asset Management LLC1,197$2.38K0.00%
EverSource Wealth Advisors, LLC671$1.33K0.00%
Denali Advisors LLC485$9650.00%
Silicon Valley Capital Partners30$600.00%
Private Advisor Group, LLC25,200$500.00%
GW&K Investment Management, LLC81$00.00%

Sold out (28)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.